Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 17 | 2023 | 98 | 6.120 |
Why?
|
| Bariatric Surgery | 12 | 2023 | 51 | 3.720 |
Why?
|
| Gastric Bypass | 12 | 2023 | 66 | 3.520 |
Why?
|
| Weight Loss | 9 | 2022 | 117 | 2.000 |
Why?
|
| Gastrectomy | 6 | 2023 | 34 | 1.870 |
Why?
|
| Laparoscopy | 11 | 2022 | 171 | 1.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2022 | 214 | 1.230 |
Why?
|
| Postoperative Complications | 6 | 2023 | 997 | 1.160 |
Why?
|
| Cholecystitis | 1 | 2023 | 10 | 0.890 |
Why?
|
| Gallstones | 1 | 2023 | 9 | 0.880 |
Why?
|
| Cefoxitin | 1 | 2020 | 3 | 0.730 |
Why?
|
| Metronidazole | 1 | 2020 | 9 | 0.730 |
Why?
|
| Levofloxacin | 1 | 2020 | 6 | 0.720 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 39 | 0.700 |
Why?
|
| Health Status Disparities | 1 | 2020 | 73 | 0.670 |
Why?
|
| Gastroplasty | 1 | 2019 | 22 | 0.640 |
Why?
|
| Reoperation | 3 | 2021 | 952 | 0.630 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 2 | 0.600 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 4 | 0.600 |
Why?
|
| Length of Stay | 2 | 2020 | 339 | 0.550 |
Why?
|
| Gene Expression | 1 | 2017 | 239 | 0.550 |
Why?
|
| Middle Aged | 18 | 2022 | 10240 | 0.540 |
Why?
|
| Adult | 15 | 2022 | 8950 | 0.520 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 60 | 0.500 |
Why?
|
| Obesity | 4 | 2022 | 307 | 0.460 |
Why?
|
| Humans | 23 | 2023 | 31073 | 0.440 |
Why?
|
| Female | 17 | 2022 | 17017 | 0.440 |
Why?
|
| Retrospective Studies | 8 | 2023 | 3665 | 0.420 |
Why?
|
| Male | 15 | 2022 | 16499 | 0.400 |
Why?
|
| Body Mass Index | 6 | 2020 | 453 | 0.380 |
Why?
|
| Postoperative Period | 4 | 2020 | 303 | 0.370 |
Why?
|
| Quality of Life | 1 | 2016 | 696 | 0.370 |
Why?
|
| Treatment Outcome | 6 | 2022 | 3810 | 0.340 |
Why?
|
| Bone Density | 2 | 2020 | 152 | 0.310 |
Why?
|
| Case-Control Studies | 4 | 2019 | 664 | 0.310 |
Why?
|
| Prospective Studies | 8 | 2022 | 1899 | 0.280 |
Why?
|
| Prognosis | 2 | 2020 | 924 | 0.250 |
Why?
|
| Insulin | 2 | 2016 | 97 | 0.230 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 5 | 0.220 |
Why?
|
| United States | 3 | 2022 | 2376 | 0.220 |
Why?
|
| Patient Readmission | 2 | 2021 | 132 | 0.200 |
Why?
|
| Aged | 7 | 2022 | 10082 | 0.200 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 1935 | 0.190 |
Why?
|
| Preoperative Period | 2 | 2019 | 76 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 31 | 0.190 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 82 | 0.180 |
Why?
|
| Biomarkers | 2 | 2020 | 734 | 0.170 |
Why?
|
| Mental Disorders | 1 | 2022 | 145 | 0.170 |
Why?
|
| Abdominal Muscles | 1 | 2020 | 9 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2020 | 22 | 0.170 |
Why?
|
| Antiemetics | 1 | 2020 | 9 | 0.170 |
Why?
|
| Protein Precursors | 1 | 2019 | 20 | 0.170 |
Why?
|
| Morphine | 1 | 2020 | 85 | 0.160 |
Why?
|
| Fractures, Bone | 1 | 2020 | 81 | 0.160 |
Why?
|
| Nerve Block | 1 | 2020 | 65 | 0.160 |
Why?
|
| Neoplasms | 1 | 2022 | 261 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2019 | 126 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2020 | 354 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 14 | 0.150 |
Why?
|
| Incidence | 2 | 2022 | 790 | 0.150 |
Why?
|
| Operative Time | 1 | 2017 | 85 | 0.150 |
Why?
|
| Blotting, Western | 1 | 2017 | 178 | 0.140 |
Why?
|
| Cystectomy | 1 | 2017 | 6 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 226 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 420 | 0.140 |
Why?
|
| Risk Factors | 3 | 2021 | 2591 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 53 | 0.140 |
Why?
|
| Urinary Bladder | 1 | 2017 | 21 | 0.140 |
Why?
|
| Time Factors | 3 | 2016 | 1680 | 0.140 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 24 | 0.140 |
Why?
|
| Anemia | 1 | 2017 | 100 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2017 | 164 | 0.140 |
Why?
|
| Adolescent | 2 | 2020 | 2403 | 0.130 |
Why?
|
| Young Adult | 2 | 2020 | 2061 | 0.130 |
Why?
|
| Sex Factors | 1 | 2017 | 510 | 0.130 |
Why?
|
| Weight Gain | 1 | 2016 | 70 | 0.130 |
Why?
|
| Hypertension | 1 | 2017 | 288 | 0.120 |
Why?
|
| Age Factors | 1 | 2017 | 875 | 0.120 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 428 | 0.120 |
Why?
|
| Mental Health | 1 | 2016 | 113 | 0.120 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 5 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2013 | 60 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2013 | 78 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 161 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 551 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 505 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2022 | 2046 | 0.060 |
Why?
|
| Fibronectins | 1 | 2022 | 33 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 128 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2021 | 150 | 0.050 |
Why?
|
| Morbidity | 1 | 2020 | 65 | 0.040 |
Why?
|
| Postmenopause | 1 | 2019 | 62 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 331 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 326 | 0.040 |
Why?
|
| Comorbidity | 1 | 2019 | 508 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2017 | 27 | 0.040 |
Why?
|
| Ureter | 1 | 2017 | 18 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 28 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2017 | 132 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 334 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 144 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 375 | 0.030 |
Why?
|
| Lipids | 1 | 2014 | 38 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 12 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 83 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2014 | 120 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2014 | 262 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 718 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 5197 | 0.020 |
Why?
|